MedPath

Observational Retrospective Study on Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy

Completed
Conditions
Hysterectomy
Pain, Postoperative
Anesthesia, Spinal
Morphine
Interventions
Procedure: Administration of morphine by intrathecal route
Procedure: Administration of morphine by intravenous route
Registration Number
NCT05654363
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

Perioperative multimodal analgesia, defined by the use of various analgesic medications targeting different drug receptors, provides adequate pain relief with minimal or no opiate consumption. Therefore, it represents one of the cornerstone of Enhanced Recovery After Surgery (ERAS) protocols, as the reduction in opioid use and the associated side effects may eventually reduce length of hospital stay, increase patient satisfaction and minimise the risk of long-term opioid use.

Regional and neuraxial anesthesia techniques are key interventions to provide successful analgesia in the context of a multimodal strategy. Intrathecal morphine, for its effectiveness and potential of reducing the need of intravenous postoperative opioids, seems an attractive option in the case of hysterectomy, one of the most common major surgical procedures performed in women, associated with severe postoperative pain even when performed laparoscopically.

The aim of our observational retrospective study is therefore to compare the analgesic efficacy and the safety of morphine administered by intrathecal route versus intravenous route during the first 48 hours after performance of laparoscopic/laparotomic hysterectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
670
Inclusion Criteria
  • Adult women American Society of Anaesthesiologists (ASA) physical status <= 3, scheduled for elective hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021.
Exclusion Criteria
  • patients with American Society of Anaesthesiologists (ASA) status > 3,
  • opioid use or history of opioid dependence,
  • chronic use of analgesic medications,
  • psychiatric disorders,
  • surgery including upper abdominal procedures (for example liver mobilization and diaphragm peritonectomy/resection, splenectomy) or xifo-pubic incision

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Intrathecal morphineAdministration of morphine by intrathecal routeAdult women American Society of Anaesthesiologists (ASA) physical status \<= 3, scheduled for elective laparoscopic/laparotomic hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021, who consented to the execution of a preoperative spinal analgesia with intrathecal morphine (as part of our standard practice) and who did not present any contraindications to lumbar puncture.
Intravenous morphineAdministration of morphine by intravenous routeAdult women American Society of Anaesthesiologists (ASA) physical status \<= 3, scheduled for elective laparoscopic/laparotomic hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021, who did not consent to the execution of a preoperative spinal analgesia or presented contraindications to lumbar puncture (coagulopathy or incorrect discontinuation of anticoagulant drugs, increased intracranial pressure, infection at the site of injection, major spinal deformities).
Primary Outcome Measures
NameTimeMethod
Numeric pain rating scale (NPRS)48 hours from baseline

Numeric pain rating scale (NPRS) (ranging from 0, "no pain" and 10, "the worst pain imaginable") at rest

Secondary Outcome Measures
NameTimeMethod
Length of hospital stayTime from dismissal from PACU to dismissal from hospital, an average of 72 hours

The Length of Hospital Stay (LOS) after the surgery

Intraoperative opioid consumptionDuring the surgery

Total opioid consumption

MobilizationAfter the end of surgery, in the first 48 postoperative hours

Time of first mobilization after the surgical procedure

Postoperative opioid consumptionAfter the end of surgery, in the first 48 postoperative hours

Total opioid consumption

Adverse eventsAfter the end of surgery, in the first 48 postoperative hours

Any adverse event, like sedation, itching, nausea, motor weakness, signs of local anesthetic toxicity

ConstipationAfter the end of surgery, in the first 48 postoperative hours

The presence of opioid-induced constipation

Rescue analgesiaAfter the end of surgery, in the first 48 postoperative hours

The use of non-opioid rescue analgesics in case of NPRS \> 3, other than around the clock pain medications

Length of PACU stayTime from admission to dismissal from PACU, an average of 1 hour

Length of stay in Postoperative Anesthesia Care Unit (PACU)

Trial Locations

Locations (1)

Catarci Stefano

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath